CopyMark Law Group
4.9
Drawing for AQXENA

USPTO serial 79298070

AQXENA

Reviewed by CopyMark Law Group

Reg. 6392049Status 700Renewal
Filing date
Status date
Registration date
Jun 22, 2021
Examiner
HOWARD, PARKER WALDRIP
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AQXENA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Assistance with this Renewal
Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software used for evaluation, assessment and analysis of pharmacokinetics in developing pharmaceutical preparations and substances; recorded computer software used for evaluation, assessment and analysis of pharmacokinetics in developing pharmaceutical preparations and substances ; Downloadable computer software used for measuring, analyzing, assessing and evaluating configuration of nucleic acid molecule; recorded computer software used for measuring, analyzing, assessing and evaluating configuration of nucleic acid molecule ; Downloadable computer software used for analyzing, assessing and evaluating data from mass analyzers; recorded computer software used for analyzing, assessing and evaluating data from mass analyzersACTIVE—
042Providing temporary use of online non-downloadable computer software used for evaluation, assessment and analysis of pharmacokinetics in developing pharmaceutical preparations and substances; providing temporary use of online non-downloadable computer software used for measuring, analyzing, assessing and evaluating configuration of nucleic acid molecule; providing temporary use of online non-downloadable computer software used for analyzing, assessing and evaluating data from mass analyzers; maintenance, design and upgrade of computer software used for evaluation, assessment and analysis of pharmacokinetics in developing pharmaceutical preparations and substances; maintenance, design and upgrade of computer software used for measuring, analyzing, assessing and evaluating configuration of nucleic acid molecule; maintenance, design and upgrade of computer software used for analyzing, assessing and evaluating data from mass analyzers; data analysis services, namely, data analysis of pharmacokinetics for scientific research purposes, data analysis in the field of nucleic acid molecule for scientific research purposes, and analysis of data from mass analyzers for scientific research purpose; computer-aided scientific research, testing and analysis services in the field of mass analysis data of nucleic acid; computerized electronic storage of data log relating to mass analysis data of nucleic acid; analyzing of data of mass of nucleic acid for scientific research purposes and electronic storage of data logACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 22, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 28, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 23, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 4, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 13, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 13, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 22, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 22, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 17, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 18, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 18, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 18, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2021RFNTREFUSAL PROCESSED BY IB—
Jan 28, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 28, 2021RFRRREFUSAL PROCESSED BY MPU—
Jan 9, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 8, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 4, 2021DOCKASSIGNED TO EXAMINER—
Jan 4, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 31, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 19, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance